Cybin (CYBN) announced that it will voluntarily transfer its U.S. stock exchange listing to Nasdaq from NYSE. The company expects that its common shares will cease trading on the NYSE American at market close on January 4, 2026 and commence trading on Nasdaq at market open on January 5, 2026.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYBN:
- Psychedelic: Clearmind reports CMND-100 dosing at Hadassah Medical Center
- Cybin price target raised to $48 from $39 at Guggenheim
- Cybin Secures $175 Million in Direct Offering to Advance Clinical Programs
- Psychedelic: Clearmind reports results from first cohort in AUD trial
- Cybin price target lowered to $45 from $70 at Canaccord